Estimation of Salivary Counts in Asthmatic Adult Patients Taking Anti-asthmatic Medication for 3-5 Years

Overview

Journal J Oral Maxillofac Pathol

Date 2019 Jan 18

PMID 30651678

Citations 1

Authors

Kumari Alka

Vikram S Amberkar

K P Mohan Kumar

D B Nandini

B Vidyasagar

Affiliations

Soon will be listed here.

Abstract

Background: Bronchial asthma is a chronic inflammatory disease of airways. The disease itself along with the principal medication used makes the oral cavity susceptible to most common opportunistic infection, i.e., oral candidiasis. There are many species of Candida causing oral candidiasis, but the most prevalent among them is . Hence, assessing count in response to disease and its treatment is necessary. This enables us to educate asthma patients about side effects of medication and highlight the necessity for oral health care, thereby improving their quality of life.

Aims: The present study aims to evaluate the effects of asthma and its medication on count in saliva samples of asthmatic adult patients taking medication for 3-5 years and compare count in saliva samples among cases and controls.

Materials And Methods: Thirty asthmatic adults taking medication for asthma since 3-5 years' age ranging from 20 to 50 years and equal number of age- and sex-matched healthy participants were included in the study. In both groups, saliva was collected and inoculated on Sabouraud Dextrose Agar culture plates for estimation of counts. counts were assessed in colony-forming unit/milliliter.

Statistical Analysis: Mann-Whitney U-test and Fisher's exact -test were used.

Results: The count is significantly higher among asthmatics than healthy individuals.

Conclusions: The present study concludes that there is increased candidal growth among asthmatics as compared to their normal healthy counterpart.

Citing Articles

Basis of preventive and non-pharmacological interventions in asthma.

Clemente-Suarez V, Mielgo-Ayuso J, Ramos-Campo D, Beltran-Velasco A, Martinez-Guardado I, Navarro Jimenez E Front Public Health. 2023; 11:1172391.

PMID: 37920579 PMC: 10619920. DOI: 10.3389/fpubh.2023.1172391.

References

Gumowski P, Lech B, Chaves I, Girard J . Chronic asthma and rhinitis due to Candida albicans, epidermophyton, and trichophyton. Ann Allergy. 1987; 59(1):48-51. View

Kantheti L, Reddy B, Ravikumar S, Anuradha C, Chandrasekhar P, Rajeswari M . Isolation, identification, and carriage of candidal species in PHLAs and their correlation with immunological status in cases with and without HAART. J Oral Maxillofac Pathol. 2012; 16(1):38-44. PMC: 3303520. DOI: 10.4103/0973-029X.92971. View

Tootla R, Toumba K, Duggal M . An evaluation of the acidogenic potential of asthma inhalers. Arch Oral Biol. 2004; 49(4):275-83. DOI: 10.1016/j.archoralbio.2003.11.006. View

Storhaug K . Caries experience in disabled pre-school children. Acta Odontol Scand. 1985; 43(4):241-8. DOI: 10.3109/00016358509046504. View

Akpan A, Morgan R . Oral candidiasis. Postgrad Med J. 2002; 78(922):455-9. PMC: 1742467. DOI: 10.1136/pmj.78.922.455. View

Godara N, Godara R, Khullar M . Impact of inhalation therapy on oral health. Lung India. 2011; 28(4):272-5. PMC: 3213714. DOI: 10.4103/0970-2113.85689. View

Thomas M, Parolia A, Kundabala M, Vikram M . Asthma and oral health: a review. Aust Dent J. 2010; 55(2):128-33. DOI: 10.1111/j.1834-7819.2010.01226.x. View

Ellepola A, Samaranayake L . Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis. 2001; 7(4):211-6. View

Zaremba M, Daniluk T, Rozkiewicz D, Cylwik-Rokicka D, Kierklo A, Tokajuk G . Incidence rate of Candida species in the oral cavity of middle-aged and elderly subjects. Adv Med Sci. 2007; 51 Suppl 1:233-6. View

10.

Cohen R, Roth F, Delgado E, Ahearn D, Kalser M . Fungal flora of the normal human small and large intestine. N Engl J Med. 1969; 280(12):638-41. DOI: 10.1056/NEJM196903202801204. View

11.

Mullaoglu S, Turktas H, Kokturk N, Tuncer C, Kalkanci A, Kustimur S . Esophageal candidiasis and Candida colonization in asthma patients on inhaled steroids. Allergy Asthma Proc. 2007; 28(5):544-9. DOI: 10.2500/aap2007.28.3046. View

12.

Powell H, Gibson P . Inhaled corticosteroid doses in asthma: an evidence-based approach. Med J Aust. 2003; 178(5):223-5. DOI: 10.5694/j.1326-5377.2003.tb05167.x. View

13.

Al-Abeid H, Abu-Elteen K, Elkarmi A, Hamad M . Isolation and characterization of Candida spp. in Jordanian cancer patients: prevalence, pathogenic determinants, and antifungal sensitivity. Jpn J Infect Dis. 2004; 57(6):279-84. View

14.

Fukushima C, Matsuse H, Saeki S, Kawano T, Machida I, Kondo Y . Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma. 2005; 42(7):601-4. DOI: 10.1080/02770900500216259. View

15.

Scully C, Samaranayake L . Candida and oral candidosis: a review. Crit Rev Oral Biol Med. 1994; 5(2):125-57. DOI: 10.1177/10454411940050020101. View

16.

Holbrook W, Kristinsson M, Gunnarsdottir S, Briem B . Caries prevalence, Streptococcus mutans and sugar intake among 4-year-old urban children in Iceland. Community Dent Oral Epidemiol. 1989; 17(6):292-5. DOI: 10.1111/j.1600-0528.1989.tb00639.x. View

17.

Hsieh C, Huang L, Tschen E, Chang C, Lee C . Five novel anamorphic, ascomycetous yeast species associated with mushrooms and soil. FEMS Yeast Res. 2010; 10(7):948-56. DOI: 10.1111/j.1567-1364.2010.00652.x. View

18.

Pfaller M, Diekema D . Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007; 20(1):133-63. PMC: 1797637. DOI: 10.1128/CMR.00029-06. View

19.

Ryberg M, Moller C, Ericson T . Effect of beta 2-adrenoceptor agonists on saliva proteins and dental caries in asthmatic children. J Dent Res. 1987; 66(8):1404-6. DOI: 10.1177/00220345870660082401. View

20.

Balan P, Gogineni S, Kumari N S, Shetty V, Lakshman Rangare A, L Castelino R . Candida Carriage Rate and Growth Characteristics of Saliva in Diabetes Mellitus Patients: A Case-Control Study. J Dent Res Dent Clin Dent Prospects. 2016; 9(4):274-9. PMC: 4753038. DOI: 10.15171/joddd.2015.048. View